Susan L Mooberry Selected Research

Susan L Mooberry Research Topics

Disease

43	Neoplasms (Cancer) 01/2023 - 01/2002
12	Triple Negative Breast Neoplasms 12/2022 - 06/2015
10	Breast Neoplasms (Breast Cancer) 10/2021 - 03/2004
3	Prostatic Neoplasms (Prostate Cancer) 03/2016 - 04/2006
3	Melanoma (Melanoma, Malignant) 06/2014 - 09/2010
2	Bites and Stings (Sting) 12/2022 - 10/2021
2	Ewing Sarcoma (Sarcoma, Ewing) 12/2021 - 01/2020
2	Leukemia 05/2009 - 04/2006
1	Medulloblastoma 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Malaria 03/2016
1	Vascular Remodeling 06/2015
1	Carcinoma (Carcinomatosis) 09/2010
1	Neuroblastoma 04/2006
1	Colonic Neoplasms (Colon Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

7	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 07/2006
7	TubulinIBA 01/2023 - 09/2005
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2023 - 02/2006
5	eribulin FDA Link 12/2022 - 06/2015
4	Colchicine FDA LinkGeneric 01/2023 - 09/2005
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2016
3	Estrogens (Estrogen)FDA Link 11/2017 - 03/2004
2	Mitochondrial DNA (mtDNA)IBA 12/2022 - 10/2021
2	Transcription Factors (Transcription Factor)IBA 12/2022 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2016
2	Antimitotic AgentsIBA 10/2021 - 04/2013
2	Immune Checkpoint InhibitorsIBA 10/2021 - 06/2021
2	SaltsIBA 11/2018 - 07/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2017 - 01/2016
2	taccalonolide AJIBA 01/2017 - 11/2011
2	maximiscinIBA 01/2016 - 01/2014
2	Docetaxel (Taxotere)FDA Link 07/2014 - 03/2014
2	Chalcone (Benzalacetophenone)IBA 10/2011 - 01/2010
2	Boronic AcidsIBA 01/2010 - 09/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2008 - 03/2004
1	pyrimidineIBA 01/2023
1	Interferon-betaIBA 12/2022
1	ADU-S100IBA 12/2022
1	CytokinesIBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	alteichinIBA 12/2021
1	altertoxin IIBA 12/2021
1	altertoxin IIIBA 12/2021
1	Cytotoxins (Cytolysins)IBA 12/2021
1	InterferonsIBA 10/2021
1	YuanhuacinIBA 06/2021
1	TetraspaninsIBA 06/2021
1	QuinazolinesIBA 01/2021
1	benzofuranIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	CardenolidesIBA 01/2020
1	ChromatinIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Small Interfering RNA (siRNA)IBA 10/2019
1	englerin AIBA 09/2019
1	Clerodane DiterpenesIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018
1	IndolesIBA 01/2017
1	trichodermamide BIBA 01/2017
1	trichodermamide AIBA 01/2017
1	LupanesIBA 03/2016
1	Antimalarials (Antimalarial Agents)IBA 03/2016
1	PyrimidinesIBA 01/2016
1	human ERBB2 proteinIBA 01/2016
1	deguelinIBA 01/2016
1	taxaneIBA 06/2015
1	halichondrin BIBA 06/2015
1	AnthracyclinesIBA 06/2015
1	Epoxy Compounds (Epoxides)IBA 07/2014
1	Sunitinib (Sutent)FDA Link 07/2014
1	heteroneminIBA 03/2014
1	12-oxoheteroneminIBA 03/2014
1	non-ribosomal peptide synthaseIBA 01/2014
1	shikimateIBA 01/2014
1	Polyketide SynthasesIBA 01/2014
1	taccabulin AIBA 10/2013
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2012
1	amyrisin AIBA 03/2012
1	KetonesIBA 10/2011
1	evelyninIBA 09/2010
1	Taxoids (Taxanes)IBA 05/2009
1	Vinca AlkaloidsIBA 05/2009
1	CurcuminIBA 07/2008
1	DepsipeptidesIBA 05/2008
1	3,5- dibromo- 4- (3,4- dimethoxyphenyl)- 1H- pyrrole- 2- carboxylic acid ethyl esterIBA 07/2007
1	AcidsIBA 04/2006
1	lophocladine BIBA 04/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2006
1	delta Opioid Receptors (delta Opioid Receptor)IBA 04/2006
1	lophocladine AIBA 04/2006
1	aurilide BIBA 04/2006
1	CB694IBA 02/2006
1	swinholide IIBA 01/2006
1	hurghadolide AIBA 01/2006
1	kulokekahilide-2IBA 08/2004
1	antineoplaston A10 (A 10)IBA 08/2004

Therapy/Procedure

10	Therapeutics 12/2021 - 03/2014
1	Immunotherapy 12/2022